About: http://webisa.webdatacommons.org/140186865

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Under ?? 314.60(b)(5), submission of an amendment to a supplement other than an efficacy or manufacturing supplement will not extend the review cycle.
http://www.w3.org/ns/prov#wasQuotedFrom	federalregister.gov